Tech Company Financing Transactions
Superfluid Dx Funding Round
On 12/21/2023, Superfluid Dx secured Series A funding from WRQ Sciences and Alzheimer's Drug Discovery Foundation.
Transaction Overview
Company Name
Announced On
12/21/2023
Transaction Type
Amount
Unknown
Round
Series A
Investors
WRQ Sciences (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
259 East Grand Ave South
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Superfluid Dx is a biotechnology company developing novel blood-based early detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gajus Worthington
Chief Scientific Officer
John Sninsky
Browse more venture capital transactions:
Prev: 12/21/2023: IntelliBoard venture capital transaction
Next: 12/21/2023: Lightyear venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs